Gradalis announced it raised $12.7 Million in an initial filing from an offering of $30 Million
PRIVATEJun 12, 2025
Amount Raised
$12.7 Million
Round Type
Venture
DallasBiotechnologyHealth CareTherapeutics
Company Information
Company
Gradalis
Location
Dallas, Texas, United States
About
Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 registration trial in patients with ovarian cancer. The company’s proprietary bi-shRNA therapy platform, which has been proven in its clinical studies, can be utilized to silence a broad range of genes and is applicable to multiple cancer types.
Fundz sees it the moment Gradalis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DallasBiotechnologyHealth CareTherapeutics